| Mrs Jeree Ellyn Barrow, MS | |
|
1333 Iris Ave, Boulder, CO 80304-2226 | |
| (303) 443-8500 | |
| Not Available |
| Full Name | Mrs Jeree Ellyn Barrow |
|---|---|
| Gender | Female |
| Speciality | Marriage & Family Therapist |
| Location | 1333 Iris Ave, Boulder, Colorado |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831494160 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 106H00000X | Marriage & Family Therapist | 65773 (California) | Secondary |
| 106H00000X | Marriage & Family Therapist | MFTC.0013416 (Colorado) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Jeree Ellyn Barrow, MS 1333 Iris Ave, Boulder, CO 80304-2226 Ph: (303) 443-8500 | Mrs Jeree Ellyn Barrow, MS 1333 Iris Ave, Boulder, CO 80304-2226 Ph: (303) 443-8500 |
News Archive
Dexcom, Inc., a leader in continuous glucose monitoring (CGM) for patients with diabetes, announced today that the U.S. Food and Drug Administration has approved the Dexcom G5 Mobile Continuous Glucose Monitoring (CGM) System.
Chelsea Therapeutics International, Ltd. reported findings from Study 305, a study evaluating the effect of Northera™ (Droxidopa), an investigational agent being studied for the treatment of neurogenic orthostatic hypotension (NOH), on patients' 24-hour blood pressure (BP) profile.
United States Drug Testing Laboratories, Inc, a reference laboratory specializing in alcohol and substances of abuse testing, released a new assay testing umbilical cord for newborn exposure in utero to Designer Stimulants/ Bath Salts on Friday, June 1, 2012. The CordStat® assay screens for the most common of designer stimulants known as "Bath Salts."
As medicine becomes both bigger and more personalized, the need for massive databases of patient records, such as the 1 million person All of Us Research Program, become increasingly essential to fueling both new discoveries and translational treatments.
Genentech, a member of the Roche Group today announced the U.S. Food and Drug Administration (FDA) has approved Herceptin (trastuzumab) in combination with chemotherapy (cisplatin plus either capecitabine or 5-fluorouracil [5-FU]) for HER2-positive metastatic (cancer that has spread) cancer of the stomach or gastroesophageal junction, in men and women who have not received prior medicines for their metastatic disease.
› Verified 1 days ago
Coco Caporal, Couples Therapy Medicare: Medicare Enrolled Practice Location: 2975 Valmont Rd Ste 300, Boulder, CO 80301 Phone: 303-415-1025 | |
Ms. Miriam F Schiff, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 5412 Idylwild Trl, Suite 102, Boulder, CO 80301 Phone: 303-619-3744 | |
Tori Dibona, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 1942 Broadway Ste 314c, Boulder, CO 80302 Phone: 702-931-4383 | |
Trina Renee Brown, MFTI Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 2825 Marine St Ste 203, Boulder, CO 80303 Phone: 720-605-6605 | |
Katherine Hunt Austin Iv, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 2305 Canyon Blvd Ste 101, Boulder, CO 80302 Phone: 303-917-5418 | |
Desirae Parker, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 1333 Iris Ave, Boulder, CO 80304 Phone: 303-413-6329 | |
Patti Sue Swope, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 3445 Penrose Place, Suite 250, Boulder, CO 80301 Phone: 303-247-0121 Fax: 303-447-6453 |